Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Dis Child ; 146(10): 1181-4, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1415046

RESUMO

OBJECTIVE: To determine the accuracy of measuring antenatal renal pelvic diameter for prediction of renal abnormalities. RESEARCH DESIGN: Prospective evaluation of all pregnant women undergoing ultrasonography. SETTING: A teaching hospital providing primary and referral maternity care. PARTICIPANTS: Fifty-six pregnant women with suspected fetal hydronephrosis or cystic lesions identified from 7500 ultrasonograms over 3 years. METHODS: Antenatal renal pelvic diameter was measured in the anteroposterior dimension. Neonates underwent postnatal ultrasonography after day 3 of life; if the results were abnormal, a cystogram and renal diuretic scan were obtained. RESULTS: None of 50 kidneys 15 mm or smaller in anteroposterior pelvic diameter had obstruction; 11 (79%) of 14 kidneys larger than 15 mm were obstructed or demonstrated vesicoureteral reflux. Of 12 kidneys believed to be multicystic before birth, five (42%) proved to have hydronephrosis. CONCLUSIONS: Since the majority of fetuses with suspected hydronephrosis proved to be normal, parents should not be unduly alarmed by the physician. Renal pelvic diameter of more than 15 mm is strongly predictive of hydronephrosis. Since severe hydronephrosis is treatable and can be mistaken for a multicystic kidney antenatally, full radiologic evaluation is needed soon after birth.


Assuntos
Anormalidades Congênitas/diagnóstico por imagem , Rim/anormalidades , Ultrassonografia Pré-Natal/normas , Anormalidades Congênitas/epidemiologia , Anormalidades Congênitas/patologia , Feminino , Hospitais de Ensino , Humanos , Ohio/epidemiologia , Valor Preditivo dos Testes , Gravidez , Resultado da Gravidez , Prevalência , Estudos Prospectivos , Grupos Raciais , Reprodutibilidade dos Testes
2.
Am J Dis Child ; 147(10): 1090-3, 1993 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8105678

RESUMO

OBJECTIVES: To compare the efficacy of 3-day vs 10-day treatment with a combination of amoxicillin and clavulanate potassium for children with uncomplicated urinary tract infections and to determine the role of host factors, including vesicoureteral reflux, and of bacterial virulence factors, including adhesins, in treatment outcome. DESIGN: Randomized, double-blind, controlled trial. SETTING: A pediatric infectious diseases clinic at an urban medical center. PATIENTS: Thirty-seven children with uncomplicated urinary tract infections. INTERVENTIONS: Treatment with 3 days or 10 days of antibiotics at a dosage of 20 mg/kg per day of amoxicillin and 5 mg/kg per day of clavulanate potassium in three divided doses. MEASUREMENTS AND MAIN RESULTS: The success rate for 10-day treatment was 82% (14/17) compared with 55% (11/20) for 3-day treatment (P = .09). Among the 35 patients infected with Escherichia coli, all 10 patients infected with adhesin-negative isolates were treated successfully regardless of the duration of treatment, whereas only 14 (56%) of the 25 infections involving adhesin-positive isolates were clinically cured (P = .015). Two of the three failures in the 10-day treatment group were in patients with reflux. CONCLUSIONS: We conclude that 3-day treatment with amoxicillin and clavulanate is insufficient for afebrile childhood urinary tract infections and that both bacterial and host factors affect treatment outcome.


Assuntos
Amoxicilina/uso terapêutico , Proteínas da Membrana Bacteriana Externa , Ácidos Clavulânicos/uso terapêutico , Infecções por Escherichia coli/tratamento farmacológico , Escherichia coli , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/microbiologia , Adesinas de Escherichia coli , Combinação Amoxicilina e Clavulanato de Potássio , Aderência Bacteriana/genética , Proteínas da Membrana Bacteriana Externa/genética , Pré-Escolar , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada/uso terapêutico , Escherichia coli/genética , Infecções por Escherichia coli/microbiologia , Feminino , Humanos , Lactente , Masculino , Óperon , Recidiva , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA